Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial
In: European journal of clinical pharmacology, Jg. 39 (1990), Heft 3
Online
unknown
Zugriff:
Doxazosin (mean dose 11 mg) given once daily in combination with 100 mg atenolol (n = 44) was compared with placebo and atenolol (n = 43) in a double-blind, multicenter study in patients with mild to moderate essential hypertension. In the atenolol/doxazosin-treated group, standing blood pressure significantly decreased by 17.0/12.3 mm Hg compared to 6.2/6.7 mm Hg in the atenolol/placebo group whereas supine blood pressure decreased by 13.2/9.8 mm Hg and 9.2/6.0 mm Hg, respectively in the two groups. Serum lipids did not change significantly in either group. The majority of side-effects reported were mild and transient. This study confirms that doxazosin may be safely combined with a beta-blocker. Doxazosin proved to be well tolerated and effective in patients with blood pressure refractory to atenolol alone.
Titel: |
Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial
|
---|---|
Autor/in / Beteiligte Person: | Westheim, A ; Dean, Sarah ; Dathan, R ; Searle, M ; C C Christensen |
Link: | |
Zeitschrift: | European journal of clinical pharmacology, Jg. 39 (1990), Heft 3 |
Veröffentlichung: | 1990 |
Medientyp: | unknown |
ISSN: | 0031-6970 (print) |
Schlagwort: |
|
Sonstiges: |
|